Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

Neumora Therapeutics (Nasdaq: NMRA) will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026 at 4:00 p.m. ET in New York.

Rhea-AI Summary

Neumora Therapeutics (Nasdaq: NMRA) will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026 at 4:00 p.m. ET in New York.

A live webcast will be available on the company’s events and presentations page and a replay will be archived for up to 30 days.

Argus Feb 4 session

-0.98% close to close Open Argus

Details

News Market Reaction – NMRA

In the Feb 4 session, NMRA declined 0.98%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Neumora’s participation in the Guggenheim Emerging Outlook: Biotech Sum...

Analysis

This announcement highlights Neumora’s participation in the Guggenheim Emerging Outlook: Biotech Summit 2026, with a fireside chat on February 11, 2026 at 4:00 p.m. ET and a webcast archived for 30 days. It continues a pattern of conference engagement similar to November 2025 events. Given recent clinical and pipeline updates, investors may focus on how management messaging at such forums frames key programs and the existing $171.5M cash position noted in prior filings.

Key Figures

Summit date and time: February 11, 2026 at 4:00 p.m. ET Webcast archive period: 30 days Current share price: $2.04 +5 more

Summit date and time

February 11, 2026 at 4:00 p.m. ET

Guggenheim Emerging Outlook: Biotech Summit fireside chat

Webcast archive period

30 days

Replay available on company website after event

Current share price

$2.04

Pre-news market context

Today’s volume

344,343 shares

Compared with 20-day average volume

20-day avg volume

2,150,972 shares

Liquidity benchmark before this news

52-week high

$3.25

Pre-news 52-week trading range

52-week low

$0.611

Pre-news 52-week trading range

Market capitalization

$336,478,113

Equity value before the conference announcement

Historical Context

5 past events · Latest: Jan 05

5 events

1. Jan 05

   Pipeline strategy update

   24h Move

   -1.5%

   Outlined 2026 strategy, KOASTAL readouts, NMRA-215 plans, and cash runway.

2. Jan 05

   Clinical data update

   24h Move

   -1.5%

   Reported positive NMRA-511 Phase 1b Alzheimer’s agitation signal-seeking results.

3. Nov 06

   Earnings and update

   24h Move

   -1.5%

   Q3 2025 results, cash of $171.5M, loan draw and pipeline milestones.

4. Nov 03

   Conference participation

   24h Move

   -0.3%

   Announced November 2025 investor conference appearances and webcast availability.

5. Oct 27

   Trial initiation

   24h Move

   +2.3%

   Initiated Phase 1 SAD/MAD study of M4 PAM NMRA-898 for neuropsychiatric disorders.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

clinical-stage biopharmaceutical, webcast

2 terms

clinical-stage biopharmaceutical medical

"Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company..."

A clinical-stage biopharmaceutical is a company that is developing medicines or biological treatments that are currently being tested in people in clinical trials to assess safety and effectiveness. For investors it signals a higher-risk, higher-reward profile: progress through human testing and regulatory milestones can sharply increase value if results are positive, while failed trials can wipe out expected future revenue — like a prototype that must prove it works before it can be sold widely.

webcast technical

"A live webcast of the fireside chat will be available on the events and presentations section..."

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026 at 4:00 p.m. ET in New York, NY.

A live webcast of the fireside chat will be available on the events and presentations section of the Company’s website at www.neumoratx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Neumora
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our therapeutic pipeline currently consists of seven neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Our work is supported by an integrated suite of translational, clinical and computational tools to generate insights that can enable precision medicine approaches. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients suffering from brain diseases.

Neumora Contact:
Helen Rubinstein
617-402-5700
Helen.Rubinstein@neumoratx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Neumora Therapeutics (NMRA) present at Guggenheim Emerging Outlook: Biotech Summit 2026?

Neumora will present on Wednesday, February 11, 2026 at 4:00 p.m. ET. According to the company, the presentation takes the form of a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit in New York City.

How can investors watch the Neumora (NMRA) fireside chat on February 11, 2026?

Investors can watch via a live webcast on the company’s events and presentations webpage. According to the company, the webcast will stream live and serve as the official broadcast for the fireside chat.

Will a replay of the Neumora (NMRA) Guggenheim fireside chat be available after the event?

Yes, a replay will be available and archived for up to 30 days after the event. According to the company, the replay will be posted on the events and presentations section of its website for later viewing.

What topics will Neumora Therapeutics (NMRA) likely cover in its Guggenheim fireside chat?

The company will discuss its clinical-stage pipeline and novel mechanisms of action for underserved diseases. According to the company, the fireside chat will focus on recent developments and program-level updates relevant to investors.

Where can I find the Neumora (NMRA) webcast link for the Guggenheim summit?

The webcast link will be posted on Neumora’s events and presentations webpage on its investor site. According to the company, the page will host the live stream and the subsequent replay for up to 30 days.